Keratoconjunctivitis Sicca: Relieving Symptoms with the Retyne Infrared Eye Treatment Mask
Keratoconjunctivitis sicca, commonly known as dry eye syndrome, is a chronic condition characterized by inadequate tear production or poor tear quality, leading to symptoms such as dryness, itching, burning, redness, and blurred vision. Treatment typically involves artificial tears, lubricating eye drops, medications to reduce inflammation, and lifestyle modifications to minimize exacerbating factors.
The Retyne Infrared Eye Treatment Mask offers a complementary approach to managing the symptoms of keratoconjunctivitis sicca. By delivering specific frequencies known for their hydrating and anti-inflammatory properties, the Retyne mask helps stimulate tear production, reduce ocular surface inflammation, and alleviate symptoms of dryness and discomfort. This innovative infrared therapy provides an adjunctive option for individuals struggling with the challenges of keratoconjunctivitis sicca, enhancing their overall ocular comfort and improving quality of life.
The Retyne eye treatment mask utilizes a general selection of frequencies (0.07, 0.12, 0.6, 0.87, 2.25, 22.5, 187.5, 396.5, 587.5, 696.5) specifically tailored to address this type of Corneal disorder. These frequencies have been selected for their proven effectiveness in managing and treating this visual condition. Retyne's approach involves converting each frequency into invisible infrared light output, marking a groundbreaking fusion of frequencies with light—a pioneering technology pioneered by Retyne Labs.
Inspired by the groundbreaking work of Dr. Rife, who identified healing properties in specific frequencies and utilized light for their transmission, Retyne's innovative method capitalizes on current research on invisible infrared technology and builds upon past studies on light transmission through frequency sources. The result is the Retyne eye Treatment Mask, a convergence of state-of-the-art advancements in the field of visual care.
Moreover, for those utilizing advanced hardware such as the RDPV4, a secondary set of specific frequencies for Keratoconjunctivitis Sicca (1227: Eye Conjunctivitis: 0.05, 0.41, 0.83, 105.21, 220.5, 347.25, 532.5, 742.5, 896.5, 975.98 ) is available. The RDPV4 offers an expanded range of frequencies, finely calibrated to provide even greater precision for the treatment of this Corneal Disorder. By incorporating this secondary set of frequencies, the RDPV4 elevates the potential therapeutic benefits of the Retyne eye Treatment Mask, catering to individuals seeking advanced solutions for their visual health needs.
The General set group exists at program 810: Corneal Disease: 0.07, 0.32, 0.95, 7.5, 84, 193.93, 237.5, 487.5, 706.21, 946.5
The Advanced Group 1227: Eye Conjunctivitis: 0.05, 0.41, 0.83, 105.21, 220.5, 347.25, 532.5, 742.5, 896.5, 975.98
Compatibility
Standalone controller (Program #2) (Controller shipped with Retyne Eye Treatment Mask)
RDPV4 (Direct connect, use group 810 & 1227)
RDPV4 Light Mask Program button 2
Click here for instructions on using the Retyne Mask + Controller
